Keratinocyte cancer

Foreword
Introduction
Summary of recommendations
Plain-language summary
1. Epidemiology
- 1. Epidemiology – Introduction
- 1.1 Epidemiology of BCC
- 1.2 Epidemiology of cSCC
2. Prevention
- 2. Prevention – Introduction
- 2.1 UV protection
- 2.2 Chemoprevention
- 2.3 Vitamin D
3. Early detection
4. Clinical features
- 4. Clinical features – Introduction
- 4.1 Clinical features of BCC
- 4.2 Clinical features of cSCC and related tumours
5. Pathology
- 5. Pathology – Introduction
- 5.1 Pathology of BCC
- 5.2 Pathology of cSCC and related tumours
- 5.3 Pathology of keratoacanthoma
- 5.4 Pathology of rare tumours
- 5.5 Biopsy considerations and the biopsy report
6. Prognosis
- 6. Prognosis – Introduction
- 6.1 Prognosis of BCC
- 6.2 Prognosis of cSCC
7. Surgical treatment
- 7. Surgical treatment – Introduction
- 7.1 Considerations before selecting surgical treatment modality
- 7.2 Optimal primary excision techniques
- 7.3 Optimal surgical technique – basal cell carcinoma
- 7.4 Considerations when planning surgical treatment for cSCC
- 7.5 Post-surgical care and interpretation of the pathology report
- 7.6 Managing incompletely resected BCC
- 7.7 Managing rapidly growing tumours
- 7.8 Mohs micrographic surgery
- 7.9 Surgical management of advanced cSCC
- 7.10 Health system implications and discussion
8. Radiotherapy
- 8. Radiotherapy – Introduction
- 8.1 Radiotherapy with or without surgical treatment
- 8.2 Radiotherapy for BCC
- 8.3 Radiotherapy for cSCC
- 8.4 Radiotherapy for regional (nodal) metastatic disease (non-distant)
- 8.5 Radiotherapy for actinic keratosis and cSCC in situ
- 8.6 Radiotherapy for keratoacanthoma
- 8.7 Recent advances in the radiotherapy of skin cancer
- 8.8 Management of radiotherapy side effects
- 8.9 Health system implications and discussion
9. Cryotherapy and electrodessication and curettage
- 9. Cryotherapy and electrodessication and curettage – Introduction
- 9.1 Cryotherapy and EDC for BCC
- 9.2 Cryotherapy and EDC for cSCC
- 9.3 Health system implications and discussion
10. Topical treatments and photodynamic therapy
- 10. Topical treatments and photodynamic therapy – Introduction
- 10.1 Topical treatments
- 10.2 Photodynamic therapy
- 10.3 Health system implications and discussion
11. Organ transplantation and conditions associated with immunosuppression
- 11. Organ transplantation and conditions associated with immunosuppression – Introduction
- 11.1 Epidemiology – immunosuppressed patients
- 11.2 Management of organ transplant recipients
- 11.3 Strategies to manage keratinocyte cancer in organ transplant recipients
- 11.4 Health system implications and discussion
12. Metastatic disease and systemic therapies
- 12. Metastatic disease and systemic therapies – Introduction
- 12.1 Systemic therapies for advanced and metastatic BCC
- 12.2 Systemic therapies for metastatic cSCC
- 12.3 Health system implications and discussion
13. Follow-up
14. The role of primary care
15. Economics of keratinocyte cancer
16. Common concerns raised by patients
Appendices
- TNM classification of primary cutaneous carcinomas
- Guideline development process
- List of clinical questions
- Technical report
- Working party members and contributors
- Declarations of interest register
- Glossary of technical terms and abbreviations

Declarations of interest register

From Cancer Guidelines Wiki

Clinical practice guidelines for keratinocyte cancer > Declarations of interest register

Jump to:navigation, search

Declarations of interest register

Last updated: 28 Aug 2019

See also: A Code of Practice for Declaring and Dealing with Competing Interests

Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Guidelines:Keratinocyte_carcinoma/Conflict_of_interest_register&oldid=213377"